KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, including engineered tumor-infiltrating lymphocyte (eTIL ®) programs, today announced ...

Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...

Sage Group reports strong growth in Q4'24 and Q1'25, driven by Sage Intacct and AI innovation. Read why SGGEF stock is a Hold ...

Contineum Therapeutics, Inc. (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology ...

Kindred Partners, LLC, an SBA-approved Mentor-Protégé Joint Venture between Knowesis, Inc. and Kymber Consulting, LLC, was awarded a 3-year contract to support the critical work of the Department of ...

Sage Therapeutics (SAGE) announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the ...

Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the Company, effective March 21, 2025. Dr.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TG Therapeutics (TGTX – Research Report), ...

Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are ...

Apogee Therapeutics, Inc. ( ($APGE) ) has released its Q4 earnings. Here is a breakdown of the information Apogee Therapeutics, Inc. presented to ...

Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has been given a consensus recommendation of “Hold” by the nineteen ratings firms that are currently covering the stock, MarketBeat.com reports.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...